Launched throughout Psoriasis Action Month, marketing campaign supplies tips and instruments for talking about psoriasis with healthcare suppliers, household, and associates

WESTLAKE VILLAGE, Calif., Aug. 30, 2022 /PRNewswire/ — Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) at this time introduced the launch of an academic marketing campaign designed to boost consciousness in regards to the bodily and emotional influence of plaque psoriasis and empower these dwelling with the illness to have open, sincere conversations with their healthcare suppliers, household, and associates. The marketing campaign, referred to as Expose Psoriasis, options knowledgeable recommendation from a number one dermatologist and the private story and tips from an award-winning author and psoriasis affected person advocate.

Experience the total interactive Multichannel News Release right here: https://www.multivu.com/players/English/9045652-arcutis-expose-psoriasis-campaign/

“Psoriasis can have a significant impact on all aspects of life, and can affect people in ways that may be unexpected, physically, mentally, and emotionally1,” stated Frank Watanabe, President and CEO of Arcutis. “Unfortunately, those with psoriasis may have difficulty discussing the full impact of their disease with their loved ones, or even their dermatology specialists, due to stigma, embarrassment, or possibly not realizing how psoriasis may be affecting them. Through Expose Psoriasis, Arcutis hopes to encourage these conversations so people with psoriasis are able to receive the appropriate treatment, care, and support that they need.”

Expose Psoriasis illuminates how plaque psoriasis could considerably influence many elements of each day life, together with day-to-day selections corresponding to what to put on, participation in social actions, and interpersonal relationships. The marketing campaign additionally goals to boost consciousness that signs could happen wherever on the physique, together with knees, elbows, torso, and delicate locations just like the face, genitals, and areas of skin-to-skin contact (intertriginous areas), corresponding to armpits, beneath the breasts, abdomen folds, between the buttocks, and within the groin space.

Psoriasis occurring on the genitals and in intertriginous areas could look totally different in comparison with plaques on different areas of the physique, and due to this fact could also be difficult to acknowledge or diagnose.2 A latest survey carried out by The Harris Poll discovered that 2 in 5 survey respondents with psoriasis in intertriginous areas didn’t acknowledge they’d intertriginous psoriasis till they noticed footage of intertriginous plaques.3

“People who experience psoriasis in more private parts of the body, such as on the genitals or intertriginous areas, may feel reluctant or embarrassed to show their dermatology specialist these areas. Additionally, since most people typically think a dermatology visit is only for discussing the physical aspects of their skin, those with psoriasis may not realize that they should be sharing how the disease is impacting their emotional and mental wellbeing,” defined Tina Bhutani, M.D., main dermatologist and co-director of the UCSF Psoriasis and Skin Treatment Center. “It’s so important for people to tell their healthcare providers about all the ways psoriasis impacts them because there are many treatment options and resources available that can help. Understanding the full impact of the disease allows dermatology specialists to determine the best course of action to care for our patients.”

Expose Psoriasis additionally addresses the worth of getting a help community and supplies speaking factors that individuals can use to debate their illness with their family members.

“Psoriasis can have an impact on your relationships with others, and talking about your symptoms with loved ones can be difficult, but it’s so important to do so,” defined Sabrina Skiles, award-winning author and psoriasis affected person advocate. “Remember, your family and friends are there to support you, not judge you. By sharing your story with them and educating them about the disease, you are normalizing the topic and strengthening your support network.”  

People inquisitive about testing their information about psoriasis can take this interactive quiz right here. For extra details about this initiative, go to www.ExposePsoriasis.com.

About Psoriasis

Psoriasis is a typical, non-contagious, immune-mediated pores and skin illness that impacts roughly 9 million folks in the United States.4 Individuals with psoriasis usually develop “plaques,” or raised, pink areas of pores and skin lined with a silver or white layer of lifeless pores and skin cells. The scientific presentation of plaques in folks with various pores and skin tones could have extra grayish, purplish, or brownish tones. Psoriatic plaques are sometimes itchy and typically painful and might seem on any space of the physique. Plaques in sure anatomical areas current distinctive remedy challenges, together with the face, elbows and knees, scalp, and intertriginous areas (the place two pores and skin areas could contact or rub collectively).

About Arcutis

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology firm that champions significant innovation to deal with the pressing wants of people dwelling with immune-mediated dermatological illnesses and circumstances. With a dedication to fixing essentially the most persistent affected person challenges in dermatology, Arcutis harnesses our distinctive dermatology growth platform coupled with our dermatology experience to construct differentiated therapies towards biologically validated targets. Arcutis’ dermatology growth platform features a strong pipeline with a number of scientific applications for a variety of inflammatory dermatological circumstances together with scalp psoriasis, atopic dermatitis, and seborrheic dermatitis. For extra info, go to www.arcutis.com or comply with Arcutis on LinkedIn, Facebook, and Twitter.

Forward-Looking Statements

This press launch comprises “forward-looking” statements, together with, amongst others, statements relating to the potential for roflumilast to revolutionize the usual of care in plaque psoriasis and different inflammatory dermatological circumstances. These statements contain substantial recognized and unknown dangers, uncertainties and different components that will trigger our precise outcomes, ranges of exercise, efficiency, or achievements to be materially totally different from the knowledge expressed or implied by these forward-looking statements and you shouldn’t place undue reliance on our forward-looking statements. Risks and uncertainties that will trigger our precise outcomes to vary embody dangers inherent within the scientific growth course of and regulatory approval course of, the timing of regulatory filings, and our skill to defend our mental property. For an additional description of the dangers and uncertainties relevant to our enterprise, see the “Risk Factors” part of our Form 10-Ok filed with U.S. Securities and Exchange Commission (SEC) on February 22, 2022, as amended, in addition to any subsequent filings with the SEC. You shouldn’t place undue reliance on any forward-looking statements on this press launch. We undertake no obligation to revise or replace info herein to replicate occasions or circumstances sooner or later, even when new info turns into out there. All forward-looking statements are certified of their entirety by this cautionary assertion, which is made beneath the secure harbor provisions of the Private Securities Litigation Reform Act of 1995.

Contacts:

Media
Amanda Sheldon, Head of Corporate Communications
[email protected]

Investors
Eric McIntyre, Head of Investor Relations
[email protected]

1 Bhosle, M.J., Kulkarni, A., Feldman, S.R. et al. Quality of life in sufferers with psoriasis. Health Qual Life Outcomes 4, 35 (2006). https://doi.org/10.1186/1477-7525-4-35.  
2 Merola JF, Qureshi A, Husni ME. Underdiagnosed and undertreated psoriasis: nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, arms, toes, and nails. Dermatol Ther. 2018;31(3):e12589. doi:10.1111/dth.12589.  
3 Data on file: REF-00574. Arcutis Biotherapeutics, 2021.  
4 Data on file: REF- 00955. Arcutis Biotherapeutics, 2022.

SOURCE Arcutis Biotherapeutics, Inc.

rt

Leave a comment

Your email address will not be published. Required fields are marked *